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Abstract
Sixteen experienced marathoners ran on treadmills for 3 h at~ 70% maximal oxygen consumption (V˙o2max) on 
two occasions while receiving 1 l/h carbohydrate (CHO) or placebo (Pla) beverages. Blood and vastus lateralis 
muscle biopsy samples were collected before and after exercise. Plasma was analyzed for IL-6, IL-10, IL-1 
receptor agonist (IL-1ra), IL-8, cortisol, glucose, and insulin. Muscle was analyzed for glycogen content and 
relative gene expression of 13 cytokines by using real-time quantitative RT-PCR. Plasma glucose and insulin were 
higher, and cortisol, IL-6, IL-10, and IL-1ra, but not IL-8, were significantly lower postexercise in CHO vs. Pla. 
Change in muscle glycogen content did not differ between CHO and Pla (P = 0.246). Muscle cytokine mRNA 
content was detected preexercise for seven cytokines in this order (highest to lowest): IL-15, TNF-α, IL-8, IL-1β, 
IL-12p35, IL-6, and IFN-γ. After subjects ran for 3 h, gene expression above prerun levels was measured for five 
of these cytokines: IL-1β, IL-6, and IL-8 (large increases), and IL-10 and TNF-α (small increases). The increase in 
mRNA (fold difference from preexercise) was attenuated in CHO (15.9-fold) compared with Pla (35.2-fold) for 
IL-6 (P = 0.071) and IL-8 (CHO, 7.8-fold; Pla, 23.3-fold; P = 0.063). CHO compared with Pla beverage 
ingestion attenuates the increase in plasma IL-6, IL-10, and IL-1ra and gene expression for IL-6 and IL-8 in 
athletes running 3 h at 70%V˙o2max despite no differences in muscle glycogen content.
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January 17, 2003; 10.1152/japplphysiol.01130.2002.—Six-
teen experienced marathoners ran on treadmills for 3 h at
70% maximal oxygen consumption (V̇O2 max) on two occa-
sions while receiving 1 l/h carbohydrate (CHO) or placebo
(Pla) beverages. Blood and vastus lateralis muscle biopsy
samples were collected before and after exercise. Plasma was
analyzed for IL-6, IL-10, IL-1 receptor agonist (IL-1ra), IL-8,
cortisol, glucose, and insulin. Muscle was analyzed for glyco-
gen content and relative gene expression of 13 cytokines by
using real-time quantitative RT-PCR. Plasma glucose and
insulin were higher, and cortisol, IL-6, IL-10, and IL-1ra, but
not IL-8, were significantly lower postexercise in CHO vs.
Pla. Change in muscle glycogen content did not differ be-
tween CHO and Pla (P  0.246). Muscle cytokine mRNA
content was detected preexercise for seven cytokines in this
order (highest to lowest): IL-15, TNF-, IL-8, IL-1, IL-
12p35, IL-6, and IFN-. After subjects ran for 3 h, gene
expression above prerun levels was measured for five of these
cytokines: IL-1, IL-6, and IL-8 (large increases), and IL-10
and TNF- (small increases). The increase in mRNA (fold
difference from preexercise) was attenuated in CHO (15.9-
fold) compared with Pla (35.2-fold) for IL-6 (P  0.071) and
IL-8 (CHO, 7.8-fold; Pla, 23.3-fold; P  0.063). CHO com-
pared with Pla beverage ingestion attenuates the increase in
plasma IL-6, IL-10, and IL-1ra and gene expression for IL-6
and IL-8 in athletes running 3 h at 70% V̇O2 max despite no
differences in muscle glycogen content.
muscle glycogen; real-time quantitative reverse transcrip-
tase-polymerase chain reaction; cortisol; glucose
THE FIRST PUBLISHED REPORT that prolonged, intensive
exercise increased plasma interleukin-6 (IL-6) oc-
curred in 1991 (17). Multiple investigations during the
1990s (13, 15, 24) revealed that plasma levels of three
anti-inflammatory cytokines [IL-6, IL-10, and IL-1 re-
ceptor agonist (IL-1ra)] were most strongly elevated
after strenuous exercise. Plasma levels of IL-8, a neu-
trophil chemotactic and activation protein, also were
reported to rise after prolonged, intense exercise (13,
24). Postexercise plasma levels are slightly increased
for the proinflammatory cytokines, tumor necrosis fac-
tor- (TNF-) and IL-1, with negligible changes re-
ported for the immunomodulatory cytokines, IL-2, IL-
12, interferon (IFN)-, and IFN- (6, 13, 24).
Investigators have sought to determine the source of
these cytokines during exercise, with most of the focus
on IL-6 (6). Using innovative techniques that included
one- and two-legged knee-extensor exercise, femoral
vein and artery catheterization, and skeletal muscle
biopsy samples for IL-6 mRNA, the team from the
Copenhagen Muscle Research Center has shown that
IL-6 is released by muscle and peritendon in the con-
tracting limb and by the brain, whereas the liver clears
IL-6 during exercise (6, 8, 9, 18, 21–23). Blood mono-
cytes do not appear to be the source of IL-6 during
exercise (6, 20).
In a series of investigations during the mid- to late
1990s, our research team showed that plasma concen-
trations of IL-6, IL-10, and IL-1ra were lower in endur-
ance athletes who ingested a 6% carbohydrate com-
pared with placebo beverage (1 l/h of exercise) (12, 14,
15). Carbohydrate ingestion harnessed other inflam-
matory indicators, including neutrophil and monocyte
blood cell counts, and granulocyte/monocyte phagocy-
tosis and oxidative burst activity (12, 14, 15). Earlier
studies had shown that carbohydrate compared with
placebo ingestion improved maintenance of blood glu-
cose levels, causing a decrease in release of ACTH,
cortisol, and epinephrine (11). Given the potential link
between stress hormones and cytokine production dur-
ing exercise, we hypothesized that carbohydrate inges-
tion attenuated anti-inflammatory cytokine production
during exercise through a blood glucose-sympathoad-
renal pathway (12, 14, 15).
Others have sought to clarify the underlying mech-
anisms in the relationship between IL-6 and carbohy-
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drate metabolism. Starkie et al. (19) reported that
skeletal muscle IL-6 mRNA expression and the rate of
decrease in muscle glycogen content were unaffected
by carbohydrate ingestion in seven men who ran or
cycled for 60 min. In this study, the plasma IL-6 re-
sponse was blunted by carbohydrate ingestion, sug-
gesting that either IL-6 production and subsequent
release from skeletal muscle was attenuated and/or
that IL-6 production from tissues other than skeletal
muscle was reduced. Steensberg et al. (21) had seven
men perform 5 h of two-legged knee-extensor exercise,
with one leg reduced in muscle glycogen content. Mus-
cle IL-6 mRNA expression and IL-6 release were aug-
mented in the glycogen-depleted leg. Other studies
indicated that IL-6 mRNA expression, the transcrip-
tion rate of the IL-6 gene, and the release of IL-6 from
the working muscle were enhanced during exercise in
the glycogen-depleted state (8, 9, 21). Although epi-
nephrine infusion does not increase plasma IL-6 to the
same levels seen during exercise (23), Helge et al. (8)
showed that epinephrine and several other factors,
including exercise intensity, muscle glucose uptake,
and muscle glycogen content, were related to IL-6
release during exercise.
It will require further research to sort out which of
these parameters most consistently causes IL-6 release
and the release of other cytokines in a variety of exer-
cise conditions. The leg extensor exercise model used in
many of the studies thus far involves concentric muscle
activity at relatively low pulmonary maximal oxygen
consumption (V̇O2 max) and plasma IL-6 levels com-
pared with prolonged running (6, 9, 21, 22). The high-
est plasma levels of IL-6, IL-10, IL-1ra, and IL-8 are
attained after high-intensity running that is sustained
for 90 min (6, 14, 24). A concentration apex is
achieved at 3–4 h with little or no further increase
measured even when the duration is extended to 27 h
during ultramarathons (13–17). We designed a study
to test the hypothesis that carbohydrate blunts plasma
levels of inflammatory cytokines by influencing muscle
glycogen content and cytokine gene expression during
prolonged, intensive exercise. Experienced maratho-
ners ran for 3 h on treadmills under carbohydrate and
placebo conditions with muscle and blood samples col-
lected pre- and postexercise. The muscle samples were
tested for gene expression of 13 different cytokines. We
hypothesized that carbohydrate ingestion would influ-
ence the rate of decrease in muscle glycogen and, as a
consequence, gene expression for several inflammatory
cytokines.
MATERIALS AND METHODS
Subjects. Sixteen experienced marathon runners were re-
cruited through a letter of invitation. Male and female run-
ners ranging in age from 25 to 60 yr were accepted into the
study if they had run at least one competitive marathon, had
been training for marathon races for 2 yr or more, and were
willing to adhere to all aspects of the research design. In-
formed consent was obtained from each subject, and the
experimental procedures were in accordance with the policy
statements of the institutional review board of Appalachian
State University.
Research design. Three to six weeks before the first test
session, subjects reported to the Appalachian State Univer-
sity Human Performance Laboratory for orientation and
measurement of body composition and cardiorespiratory fit-
ness. Body composition was assessed by hydrostatic weigh-
ing, and V̇O2 max was determined by using a graded maximal
protocol adapted for runners as described in earlier studies
from our group (14–16). Oxygen uptake and ventilation were
measured by using the MedGraphics CPX metabolic system
(MedGraphics, St. Paul, MN). Heart rate was measured by
using a chest heart rate monitor (Polar Electro, Woodbury,
NY). Basic demographic and training data were obtained
through a questionnaire.
Subjects functioned as their own controls and came back to
the lab for two 3-h runs on the treadmill and ingested
carbohydrate or placebo beverages in a randomized, counter-
balanced design. Subjects reported to the lab at 6:00 AM not
having ingested energy in any form for at least 8 h. The two
runs were 4–6 wk apart, and three to four marathoners ran
on treadmills in the same room at the same time on the same
day of the week (7:00–10:00 AM, Saturday), with metabolic
measures collected every 30 min to verify workload (using
the same equipment used during baseline testing). On the
test days, subjects received 6% carbohydrate or placebo bev-
erages 15–30 min pre-run (12 ml/kg) and during the 3-h run
(4 ml  kg1  15 min1). Beverages were supplied by the
Gatorade Sports Science Institute (Barrington, IL) as in
earlier studies (12, 14, 15). The carbohydrate and placebo
beverages were identical in appearance and taste. The two
fluids were identical in sodium (19.0 meq/l) and potassium
(3.0 eq/l) concentration and pH (3.0). No other beverages
or food were ingested during this time. Blood, saliva, and
skeletal muscle biopsy samples were collected 30 min pre-
run and immediately postrun.
Five control subjects were recruited who sat in the lab
during the 3-h treadmill run sessions. Blood and muscle
samples were collected from these subjects before and after
sitting in the lab by using the same procedures as described
for the runners. These samples were analyzed to control for
the effect of laboratory measurements and, in particular, the
muscle biopsy procedure and the diurnal effect on plasma
cortisol.
Runners agreed to avoid the use of large-dose vitamin/
mineral supplements (above 100% of recommended dietary
allowances), herbs, and medications known to affect immune
function for 1 wk before each run. During orientation, a
dietitian instructed the runners to follow a diet high in
carbohydrate during the 3 days before each 3-h run (through
use of a food list) and record intake in a food record. The food
records were analyzed by using a computerized dietary as-
sessment program (Food Processor, ESHA Research, Salem,
Oregon).
Skeletal muscle biopsies. Skeletal muscle biopsy samples
were acquired before and after exercise after blood/saliva
sample collection. The exact same procedures were utilized
pre- and postexercise, with incisions made in the same thigh
3 cm apart. During the second 3-h treadmill run, samples
were collected from the opposite thigh. Local anesthesia (1%
xylocaine) was injected subcutaneously into the vastus late-
ralis. A muscle biopsy sample was then obtained by using the
percutaneous needle biopsy procedure modified to include
suction (1, 5). Muscle biopsy samples were divided into two
pieces and immediately frozen in liquid nitrogen. Samples
were stored at 80°C until subsequent analysis.
Muscle glycogen analysis. Samples were later freeze dried,
powdered, and dissected free of connective tissue, blood, and
other non-muscle constituents. A portion of the muscle was
extracted with acid, neutralized, and glucosyl units were
analyzed enzymatically in triplicate by using a spectropho-
tometer (7).
Total RNA isolation and cDNA. Synthesis Procedures for
RNA isolation were adapted from Carson and Booth (2).
Briefly, skeletal muscle tissue was homogenized under liquid
nitrogen with a Polytron, and total RNA was extracted by
using the guanidine thiocynate method of Chomczynski and
Sacchi (3) with Trizol reagent (Life Technologies, GIBCO-
BRL). The extracted RNA (2.5 l of sample) was dissolved in
diethylpyrocarbonate-treated water and quantified spectro-
photometrically at a 260-nm wavelength. RNA was reverse
transcribed into cDNA in a 100-l reaction volume contain-
ing 34.75 l of RNA (1.5 g) in RNase-free water, 10 l of
10 RT buffer, 22 l of 25 mM MgCl2, 20 l of deoxyNTP
(dNTP) mixture, 5 l of random hexamers, 2 l of RNase
inhibitor, and 6.25 l of multiscribe RT (50 U/l). Reverse
transcription was performed at 25°C for 10 min, 37°C for 60
min, and 95°C for 5 min, followed by quick chilling on ice, and
stored at 20°C until subsequent amplification.
Quantitative real-time RT-PCR analysis. Quantitative
real-time RT-PCR analysis was done as per manufacturer’s
instructions (Applied Biosystems) by using predeveloped as-
say reagents (IL-6) and Taqman cytokine gene expression
plate 1 (IL-1, IL-1, IL-2, IL-4, IL-5, IL-8, IL-10, IL-12p35,
IL-12p40, IFN-, IL-15, and TNF-). DNA amplification was
carried out in 25 l of Taqman Universal PCR Master Mix
(AmpliTaq Gold DNA polymerase, passive reference 1,
buffer, dNTPs, AmpErase UNG), 2 l of cDNA, 18 l of
RNase-free water, and 2.5 l of 18S primer (VIC) and 2.5 l
of primer (FAM) (for endogenous reference and target cyto-
kine) in a final volume of 50 l/well. Human control RNA
(calibrator RNA) was also used and served as a calibrator for
each plate. Samples were loaded in a MicroAmp 96-well
reaction plate. For the Taqman cytokine gene expression
plate 1, all 12 cytokine primers and probes were dried and
preloaded in a MicroAmp 96-well reaction plate by the man-
ufacturer. Two dye layers were used for the quantification of
the target cytokine mRNA (FAM) and the 18S ribosomal
RNA endogenous control (VIC). Plates were run by using ABI
sequence detection system. After 2 min at 50°C and 10 min at
95°C, plates were coamplified by 50 repeated cycles of which
one cycle consisted of 15 s denaturing step at 95°C and 1 min
annealing/extending step at 60°C. Data were analyzed by
ABI software by using the cycle threshold (CT), which is the
value calculated and based on the time (measured by PCR
cycle number) at which the reporter fluorescent emission
increases beyond a threshold level (based on the background
fluorescence of the system) (25), and it reflects the cycle
number at which the cDNA amplification is first detected.
This method was able to detect our endogenous control (18S)
and genes of interest in a single well. The primers for 18S
were limited to ensure that adequate amounts of reagents
were available for amplification of both genes. 18S was de-
tected in the same well as the cytokine gene of interest
because the reporter dyes, which attached to the Taqman
probes, fluoresce at different wavelengths. Detectable cyto-
kine mRNA was determined by using the change in CT (	CT)
values for each muscle sample. A 	CT value of 26 (FAM CT
minus VIC CT) was considered the minimally detectable
concentration in this assay.
Samples were initially run in duplicate on three cytokine
plates and one IL-6 plate to determine intra-assay coefficient
of variance (CV) as well as interassay CV. Intra-assay CVs
were 1.65, 2.40, and 2.09% for the FAM, VIC, and 	CT,
respectively. Interassay CVs were 3.95 and 5.73% for the
cytokine plate and IL-6, respectively. On the basis of this
initial data, the remaining samples were run in singles.
Calculations for relative quantification. Quantification of
cytokine gene expression was calculated by using the 	CT
method as described by Livak and Schmittgen (10). This
method uses a single sample, the calibrator sample, for
comparison of every unknown sample’s gene expression. This
method of analysis and quantification has been shown to give
similar results as the standard curve method (25). Briefly,
	CT [CT(FAM)  CT(VIC)] was calculated for each sample and
calibrator. 		CT [	CT(calibrator)  	CT(sample)] was then cal-
culated for each sample, and relative quantification was
calculated as 2		CT. Initial exclusion criteria consisted of
FAM CT  40 and VIC CT  23. All samples had FAM CT
values of between 25 and 38. A one-unit change in CT reflects
a twofold change in mRNA content. Lower CT values reflect
higher mRNA levels. Detectable cytokine gene expression
(mRNA) was defined as a 	CT value of 26. This reflects a
FAM CT value of 36 with an average VIC CT value that was
very consistent at 10.2. The unusually high levels of IL-10
and TNF- mRNA in the human calibrator mRNA resulted
in a very low 		CT (and resulting relative fold difference
from calibrator) value for these cytokines in the muscle
samples, which does not necessarily indicate a low level of
IL-10 and TNF- mRNA in the samples.
Blood cell counts, hormones, and glucose. Blood samples
were drawn from an antecubital vein with subjects in the
seated position. Routine complete blood counts were per-
formed by our clinical hematology laboratory and provided
leukocyte subset counts, hemoglobin, and hematocrit. Other
blood samples were centrifuged in sodium heparin tubes, and
plasma was aliquoted and then stored at 80°C. Plasma
cortisol was assayed in duplicate by using the competitive
solid-phase 125I radioimmunoassay technique (Diagnostic
Products, Los Angeles, CA). Radioimmunoassay kits were
also used to determine plasma concentrations of insulin in
duplicate according to manufacturer’s instructions (Diagnos-
tic Products). Plasma was analyzed spectrophotometrically
for glucose. Plasma volume changes were estimated by using
the method of Dill and Costill (4).
Plasma cytokine measurements. Total plasma concentra-
tions of IL-1ra, IL-6, IL-8, and IL-10 were determined by
using quantitative sandwich ELISA kits provided by R&D
Systems (Minneapolis, MN). All samples and provided stan-
dards were analyzed in duplicate. A high-sensitivity kit was
used to analyze IL-6 in the prerace plasma samples. A stan-
dard curve was constructed by using standards provided in
the kits, and the cytokine concentrations were determined
from the standard curves by using linear regression analysis.
The assays were a two-step “sandwich” enzyme immunoas-
say in which samples and standards were incubated in a
96-well microtiter plate coated with polyclonal antibodies for
the test cytokine as the capture antibody. After the appro-
priate incubation time, the wells were washed, and a second
detection antibody conjugated to either alkaline phosphatase
(IL-6 high sensitivity) or horseradish peroxidase (IL-1ra,
IL-6, IL-8, IL-10) was added. The plates were incubated and
washed, and the amount of bound enzyme-labeled detection
antibody was measured by adding a chromogenic substrate.
The plates were then read at the appropriate wavelength
(450  570 nm for IL-1ra, IL-6, IL-8, and IL-10; 490  650
nm for IL-6 high sensitivity). The minimum detectable con-
centration of IL-1ra was 
22 pg/ml, IL-6 
0.70 pg/ml, IL-6
high sensitivity 
0.094 pg/ml, IL-8 
10 pg/ml, and IL-10

3.9 pg/ml. Because of the lack of high-sensitivity kits for
IL-8 and IL-10, we extrapolated data below the minimum
detectable level by using a software program suited to this
task. Pre- and postexercise samples for IL-8, IL-10, and
IL-1ra were analyzed on the same assay plate to decrease
inter-kit assay variability.
Salivary samples. Unstimulated saliva was collected by
expectoration into 15-ml plastic, sterilized vials for 4 min.
Participants were urged to pass as much saliva as possible
into the vials during the 4-min timed session. The saliva
samples were frozen at 80°C until analysis. Saliva volume
was measured to the nearest 0.1 ml, and saliva total protein
was quantified by using the Coomassie protein assay re-
agent. Salivary IgA was measured by enzyme-linked immu-
nosorbent assay according to the procedures adapted from
the Hunter Immunology Unit (Royal Newcastle Hospital,
Newcastle, Australia). Data were expressed as concentration
of sIgA relative to total protein concentration (g/mg).
Statistical analysis. Statistical significance was set at the
P  0.05 level, and values are expressed as means  SE.
Performance measures were compared under carbohydrate
and placebo conditions by using paired t-tests. Data in Tables
3–5 and all figures were analyzed by using a 2 (carbohydrate
and placebo conditions)  2 (times of measurement) re-
peated-measures ANOVA. If the condition  time interaction
P value was 0.05, the change from pre- to postexercise
values was calculated and compared between conditions by
using paired t-tests. Pearson product-moment correlations
were used to test the relationship between changes in plasma
and muscle measures.
RESULTS
Table 1 summarizes subject characteristics for the
16 runners (12 men, 4 women) completing all phases of
the study. Data for the male and female runners were
combined because no significant differences were mea-
sured for the hormonal and immune data reported in
this paper. The marathon runners in this study were
highly experienced and committed to regular training
and racing but were still well below elite status. The
treadmill test data indicate a high degree of cardiore-
spiratory fitness for this age group. Carbohydrate in-
take during the 3 days before the 3-h treadmill runs
did not differ significantly between carbohydrate and
placebo conditions (58.8  3.1 and 61.8  2.1% of total
energy intake, respectively; P  0.271).
Oxygen consumption was measured six times during
the 3-h treadmill runs and averaged 30.9  1.0 (69.1 
1.2% V̇O2 max) and 31.4  0.9 ml  kg1  min1 (70.3 
1.3% V̇O2 max) in the carbohydrate and placebo condi-
tions, respectively (P  0.176). Heart rates during the
3-h treadmill runs averaged 81.4  1.1 and 81.5 
1.3% maximal heart rate in the carbohydrate and pla-
cebo conditions, respectively (P  0.922). Plasma vol-
ume shift was negligible and did not differ between
carbohydrate and placebo conditions (1.9  0.3 and
1.5  0.6%, respectively; P  0.597).
The increase in blood cell counts for total leukocytes,
granulocytes, and monocytes was attenuated in the
carbohydrate compared with placebo condition (Table
2). Mean granulocytosis was 94 and 182%, and mono-
cytosis was 2 and 43% in the carbohydrate and placebo
conditions, respectively (P 
 0.001). Postexercise levels
of blood lymphocytes were significantly lower in the
Fig. 1. The decrease in skeletal muscle glycogen content did not
differ in 16 runners under carbohydrate and placebo conditions after
a 3-h treadmill run at 70% maximal oxygen consumption (V̇O2max)
[F(1,15)  1.46, P  0.246]
50.01.5
1.760.02
73.23.2
16.61.0
1683
V̇ 45.01.7
1.110.02
1186
62.67.6
Values are means  SE of n  16 subjects.
Table 2. Change in blood leukocyte subset counts in 16 runners under carbohydrate and placebo conditions
after a 3-h treadmill run at 70% V̇O2max
Variable (109  I1)
Carbohydrate Placebo
P Values:
InteractionPrerun Postrun Prerun Postrun
Total leukocytes 5.210.29 7.620.55* 4.990.29 10.020.75 
0.001
Granulocytes 2.990.22 5.800.47* 2.780.24 7.830.63 
0.001
Monocytes 0.440.03 0.450.04* 0.420.03 0.600.06 
0.001
Lymphocytes 1.570.08 1.280.12* 1.610.10 1.500.12 0.036
Values are means  SE. *Significant difference in change in carbohydrate compared with placebo condition (P 
 0.05).
Table 1. Subject characteristics
Age, yr
Stature, m
Body mass, kg
Body composition, %fat
Heart rate (maximal), beats/min
O2max, ml  kg1min1
Respiratory exchange ratio (maximal) 
Minute ventilation, maximal, l/min 
Training distance, km/wk
carbohydrate compared with placebo condition (P 
0.036).
The skeletal muscle biopsy procedure was initiated
immediately postrun, with samples removed from the
vastus lateralis 14.1  0.8 and 13.1  1.0 min postrun
in the carbohydrate and placebo conditions, respec-
tively (P  0.419). Muscle glycogen decreased signifi-
cantly under both carbohydrate (28%) and placebo
(34%) conditions at a similar rate [F(1,15)  1.46, P 
0.246] (Fig. 1). The pattern of change in plasma glucose
and insulin was significantly different between condi-
tions, with postrun levels higher in the carbohydrate
condition (Table 3). Figure 2 indicates that plasma
cortisol decreased 60% in the five sitting controls, com-
pared with 24 and 3.4% in the runners during carbo-
hydrate and placebo conditions, respectively [F(1,15) 
6.26, P  0.024]. The pattern of increase in plasma
IL-6, IL-10, and IL-1-ra, but not IL-8, was significantly
different between conditions, with postrun levels lower
in the carbohydrate condition (Fig. 3 and Table 3).
Salivary IgA-to-protein ratio decreased 46 and 52% in
the carbohydrate and placebo conditions, respectively
(interaction effect, P  0.624) (Table 3).
In these subjects, muscle cytokine mRNA content
was detected preexercise for seven cytokines in this
order (highest to lowest mRNA concentration): IL-15,
TNF-, IL-8, IL-1, IL-12p35, IL-6, and IFN- (Table
4). IL-10 mRNA content in preexercise muscle samples
was just below the minimally detectable concentration
(	CT  26.4). IL-1, IL-6, IL-8, IL-10, and TNF- were
significantly increased with exercise (P 
 0.05) (Table
5 and Figs. 4–6). The increase in mRNA (difference
from preexercise) was attenuated in carbohydrate
(15.9-fold) compared with placebo (35.2-fold) for IL-6
(P  0.071) and IL-8 (carbohydrate, 7.8-fold; placebo,
23.3-fold; P  0.063), but not IL-1 (Figs. 4–6). As
depicted in Figs. 4–6, the muscle biopsy procedure did
not increase gene expression for IL-6, IL-8, and IL-1
in the sitting controls. No significant increase in gene
expression was measured in the sitting controls for
other cytokines listed in Table 4 except for TNF-
(0.031  0.003, 0.046  0.008-fold difference from
calibrator, P  0.041, first and second samples, respec-
tively). Plasma levels for IL-6, IL-10, IL-8, and IL-1ra
did not increase significantly in the sitting controls
(data not shown).
Fig. 2. Plasma cortisol decreased 60% in the 5 sitting controls com-
pared with 24 and 3.4% in the runners during carbohydrate and
placebo conditions, respectively [F(1,15)  6.26, P  0.024]. *Signif-
icant difference in change in carbohydrate compared with placebo
condition (P 
 0.05).
Fig. 3. Pattern of increase in plasma IL-6 was significantly different
between conditions, with postrun levels being lower in the carbohy-
drate condition. *Significant difference in change in carbohydrate
compared with placebo condition (P 
 0.05).
Table 3. Change in plasma glucose, insulin, cytokines, and salivary IgA to protein ratio in 16 runners under
carbohydrate and placebo conditions after a 3-h treadmill run at 70% V̇O2max
Variable
Carbohydrate Placebo
P Values:
InteractionPrerun Postrun Prerun Postrun
Glucose, mmol/l 3.840.2 5.170.2* 3.750.1 4.020.2 0.003
Insulin, pmol/l 63.66.7 12626* 77.010.6 67.28.8 0.008
IL-10, pg/ml 4.091.08 13.33.7* 3.791.02 20.45.7 0.013
IL-1ra, pg/ml 22725 30632* 19724 41858 0.002
IL-8, pg/ml 6.511.09 12.21.1 7.911.02 13.31.6 0.873
sIgA:protein, g/mg 568171 30940 627135 30247 0.624
Values are means  SE. *Significant difference in change in carbohydrate compared with placebo condition (P 
 0.05).
Change in skeletal muscle IL-6, IL-8, and IL-1
mRNA content was correlated with each other and
changes in all other variables measured in this study
for carbohydrate and placebo conditions. In both the
carbohydrate and placebo conditions, IL-1 gene ex-
pression correlated significantly with IL-6 gene expres-
sion (r  0.79, P 
 0.001, and r  0.91, P 
 0.001,
respectively). In the placebo but not the carbohydrate
condition, IL-6 and IL-1 gene expression correlated
significantly with IL-8 gene expression (r  0.90, P 

0.001, and r  0.87, P 
 0.001, respectively) and
change in plasma IL-8 (r  0.73, P  0.001, and r 
0.86, P 
 0.001, respectively). In the placebo condition
only, change in the blood lymphocyte count correlated
significantly with IL-6, IL-1, and IL-8 gene expression
(r  0.65, P  0.006; r  0.64, P  0.008; and r  0.67,
P  0.005, respectively). Change in muscle glycogen
content, plasma glucose levels, or plasma cortisol levels
did not significantly correlate with IL-6, IL-1, or IL-8
gene expression.
DISCUSSION
Our data indicate that muscle cytokine mRNA con-
tent can be detected in samples taken from marathon
runners in the resting state for IL-15, TNF-, IL-8,
IL-1, IL-12p35, IL-6, and IFN- but not IL-1, IL-2,
IL-4, IL-5, IL-10, and IL-12p40. After subjects ran for
3 h, gene expression above prerun levels was measured
for five of these cytokines: IL-1, IL-6, and IL-8 (largest
increases), and IL-10 and TNF- (smaller increases).
Preexercise, the concentration of mRNA for IL-10 and
IL-6 was minimally detectable, and postexercise the
increase in IL-10 was small compared with the large
increase in IL-6.
As in previous studies from our laboratory, carbohy-
drate compared with placebo ingestion attenuated
post-run increases in three anti-inflammatory cyto-
kines in the plasma: IL-6, IL-1ra, and IL-10 (12, 14,
15). The increase in skeletal muscle mRNA was con-
siderably diminished in the carbohydrate compared
with placebo condition for IL-6 and IL-8, but not IL-,
despite no differences in postrun muscle glycogen lev-
els. Carbohydrate ingestion did not alter the exercise-
induced increase in plasma IL-8 but did diminish IL-8
mRNA, suggesting an additional source other than
muscle for IL-8 or an alteration of production/disap-
pearance. Carbohydrate ingestion decreased the exer-
cise-induced increase in plasma IL-10 but did not alter
the small but significant gene expression for this cyto-
Table 4. Detectable cytokine mRNA in preexercise
skeletal muscle samples
Cytokine 	CT
IL-15 18.00.5
TNF- 22.30.5
IL-8 23.60.5
IL-1 23.70.5
IL-12p35 24.40.5
IL-6 25.40.3
IFN- 25.70.5
Values are means  SE of n  31 subjects. Detectable cytokine
mRNA was determined by using the change in cycle threshold (	CT)
values for each cytokine mRNA in each muscle sample. A 	CT value
of 26 (FAM CT minus VIC CT) was considered the minimally detect-
able concentration in this assay. The VIC CT values were very
consistent at 10.2. For comparison purposes for these cytokines,
the first 1-unit increase in 	CT reflects a twofold decrease in mRNA
content, and then fourfold, eightfold, etc. For example, it is reason-
able to suggest that the TNF- mRNA content is approximately
eightfold greater than the IL-6 mRNA content in the preexercise
muscle samples.
Table 5. Change in skeletal muscle cytokine mRNA content in 16 runners under carbohydrate and placebo
conditions after a 3-h treadmill run at 70% V̇O2max
Variable
Carbohydrate Placebo
P Values:
Interaction; TimePrerun Postrun Prerun Postrun
IL-1 0.820.09 1.420.38 1.060.19 3.111.48 0.373,
0.097
IL-2 2.100.68 2.590.59 1.370.23 1.450.31 0.581,
0.434
IL-4 0.120.05 0.120.05 0.160.05 0.130.04 0.182,
0.471
IL-5 0.390.11 0.520.12 0.580.17 0.790.18 0.717,
0.304
IL-10 0.0010.0001 0.0030.001 0.0020.0001 0.0040.001 0.267,
0.001
IL-12p35 5.451.22 5.611.26 6.101.34 7.761.97 0.444,
0.396
IL-12p40 0.270.14 0.330.22 0.080.02 0.150.03 0.946,
0.229
IL-15 11211.8 99.211.5 14522.3 12314.2 0.630,
0.067
IFN- 1.540.62 2.081.79 2.401.12 0.570.17 0.126,
0.499
TNF- 0.0240.003 0.0460.008 0.0280.005 0.0570.008 0.192,
0.001
Values (fold difference from calibrator) are means  SE. The very low values for IL-10 and TNF- reflect the large quantity of mRNA for 
these cytokines in the calibrator mRNA sample. It does not necessarily reflect a low concentration of mRNA in the experimental samples.
kine. Both carbohydrate and exercise may exert an
influence on IL-10 production in another body compart-
ment. Exercise strongly induced IL-1 mRNA expres-
sion irrespective of carbohydrate ingestion, suggesting
that this proinflammatory cytokine is countered by a
rapid anti-inflammatory response that successfully
combats its elevation in the plasma. In both the carbo-
hydrate and placebo conditions, IL-1 gene expression
correlated strongly with IL-6 gene expression; in the
placebo condition only, IL-6 and IL-1 gene expression
correlated significantly with IL-8 gene expression.
These correlational data suggest that long-duration
running with or without carbohydrate induces IL-1
mRNA expression but that concomitant or subsequent
IL-6 and IL-8 mRNA expression is decreased when
carbohydrate is ingested.
These data contrast with those of Starkie et al. (19).
Skeletal muscle IL-6 mRNA expression was measured
in samples obtained from seven men preexercise and
increased 20-fold after 60 min of moderate running or
cycling despite no differences in postexercise muscle
glycogen levels. IL-6 mRNA expression was similar
whether these subjects ingested a carbohydrate bever-
age (12 ml/kg, 6.4% carbohydrate, 64 g total) or
water. In contrast, IL-6 mRNA expression increased
16-fold above rest in our subjects, who ingested 60
g carbohydrate/h compared with 35-fold in the pla-
cebo condition during 3-h of treadmill running. Starkie
et al. (19) also reported significantly diminished post-
exercise levels of plasma IL-6 in the carbohydrate
compared with water condition and reasoned that ei-
ther IL-6 production and subsequent release from skel-
etal muscle was attenuated, and/or that IL-6 produc-
tion from tissues other than skeletal muscle was re-
duced. In our study, post-run plasma IL-6 was about
twice as high as reported by Starkie et al. (19) and
increased 507% above prerun levels in the carbohy-
drate condition compared with a 875% increase in the
placebo condition. Taken together, our data indicate
that the diminished postrun plasma IL-6 concentration
is at least in part due to an attenuation of skeletal
muscle IL-6 mRNA expression. Our data may differ
Fig. 4. Pattern of increase in muscle IL-1 mRNA expression after
3 h of running did not differ between conditions [F(1,15)  0.22, P 
0.645]. No significant change in muscle IL-1 mRNA expression was
measured in sitting controls experiencing the same muscle biopsy
procedure (P  0.582).
Fig. 5. Pattern of increase in muscle IL-6 mRNA expression after 3 h
of running tended to differ between conditions [F(1,15)  3.79, P 
0.071], with lower postrun expression in the carbohydrate condition.
No significant change in muscle IL-6 mRNA expression was mea-
sured in sitting controls experiencing the same muscle biopsy proce-
dure (P  0.381).
Fig. 6. Pattern of increase in muscle IL-8 mRNA expression after 3 h
of running tended to differ between conditions [F(1,15)  4.04, P 
0.063], with lower postrun expression in the carbohydrate condition.
No significant change in muscle IL-8 mRNA expression was mea-
sured in sitting controls experiencing the same muscle biopsy proce-
dure (P  0.994).
from those of Starkie et al. (19) because of the contrast
in metabolic workload and duration of exercise (3 h
compared with 1 h).
Febbraio and Pedersen (6) have hypothesized that
muscle glycogen availability may influence key signal-
ing molecules (presently undetermined) to enhance
IL-6 gene transcription within skeletal muscle during
altered homeostasis. Keller et al. (9) showed that 180
min of two-legged knee-extensor exercise activated
transcription of the skeletal muscle IL-6 gene and that
this response was enhanced under conditions in which
muscle glycogen concentrations were low. Our data
indicate that IL-6 mRNA expression is influenced by
additional factors that can be altered by carbohydrate
ingestion. Helge et al. (8), using a knee-extension ex-
ercise model and catheters in the femoral artery and
veins, showed that thigh IL-6 release was significantly
related to exercise intensity, thigh glucose uptake,
arterial plasma epinephrine concentration, and postex-
ercise glycogen concentration. Multiple studies have
shown that epinephrine is an inducer of cytokine re-
lease during exercise (for review, see Ref. 24) and that
carbohydrate ingestion blunts epinephrine release by
increasing blood glucose (11). We did not measure
epinephrine in this study but did show a consistent
relationship between the blood lymphocyte count and
IL-6, IL-1, and IL-8 gene expression in the placebo
condition. Epinephrine plays a key role in exercise-
induced changes in lymphocyte number (22). Thus it is
likely that, despite no differences in postrun muscle
glycogen levels, IL-6 mRNA and IL-8 mRNA expres-
sion in our subjects was diminished in the carbohy-
drate compared with placebo condition due in part to
differences in blood glucose and epinephrine levels.
We conclude that carbohydrate compared with pla-
cebo ingestion during a 3-h treadmill run attenuates
plasma levels of IL-1ra, IL-6, and IL-10 and muscle
gene expression for IL-6 and IL-8. Blood and muscle
samples were obtained as quickly as possible postexer-
cise, and additional samples during recovery should
provide important information in future studies. The
3-h treadmill run in both the carbohydrate and placebo
conditions induced gene expression within the muscle
for two primary proinflammatory cytokines IL-1 and
TNF-. IL-6 and IL-8, which are often considered to be
components of the secondary inflammatory cascade,
were also expressed, but to a smaller degree within the
carbohydrate condition. Anti-inflammatory indicators,
including plasma IL-1ra, IL-10, and cortisol, were also
decreased within the carbohydrate condition. To-
gether, these data suggest that carbohydrate ingestion
attenuates the secondary but not the primary proin-
flammatory cascade, decreasing the need for immune
responses related to anti-inflammation.
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